Breaking news:Baltimore Orioles reveal 2 SP targets to perfectly replace Corbin Burnes.

The Baltimore Orioles are proactively seeking to strengthen their starting rotation in anticipation of ace pitcher Corbin Burnes’ potential departure in free agency. Two prominent targets have emerged as potential replacements: Japanese right-hander Tomoyuki Sugano and left-handed pitcher Sean Manaea.

Tomoyuki Sugano

On December 17, 2024, the Orioles signed 35-year-old Tomoyuki Sugano to a one-year, $13 million contract. ​​ Sugano brings a wealth of experience from his 12-year tenure with Nippon Professional Baseball’s Yomiuri Giants, where he achieved a 136-74 record with a 2.43 ERA. His 2024 season was particularly impressive, boasting a 15-3 record and a 1.67 ERA, earning him Central League MVP honors. Sugano’s diverse pitch arsenal includes a four-seam fastball, two-seamer, cutter, slider, splitter, and curveball, making him a versatile addition to the Orioles’ rotation. ​​

Sean Manaea

In addition to Sugano, the Orioles are reportedly interested in signing free-agent left-hander Sean Manaea. Predictions suggest a potential four-year, $72 million deal. ​​ Manaea, known for his durability and consistent performance, could provide the Orioles with a reliable left-handed option in the rotation.

Strategic Implications

The Orioles’ pursuit of Sugano and Manaea reflects a strategic effort to mitigate the potential loss of Burnes and address recent injuries within their pitching staff. With key pitchers like Tyler Wells and Kyle Bradish undergoing elbow surgery, these acquisitions aim to bolster the rotation’s depth and experience. Sugano’s signing, in particular, adds a seasoned veteran with a proven track record, while Manaea’s potential addition would further solidify the starting lineup.

As the offseason progresses, the Orioles’ moves indicate a commitment to maintaining a competitive edge in the upcoming season, ensuring that the pitching staff remains robust and capable, even in the face of significant changes.

​​​​

Be the first to comment

Leave a Reply

Your email address will not be published.


*